Electronic health record
Electronic health record (EHR) is a digital version of a patient's medical history, maintained by the healthcare provider. It contains the patient's medical and treatment history, including information such as diagnoses, medications, test results, and other relevant clinical data.
Lab products found in correlation
9 protocols using electronic health record
Multimodal Approach to Increase COVID-19 Vaccine Uptake
ECMO Database Retrospective Cohort Study
COVID-19 D-Dimer Surveillance in Hospitalized Patients
Patients hospitalized with a positive polymerase chain reaction test for COVID-19 were eligible for this retrospective, observational study if ≥1 D-dimer was measured during hospital admission. At all 4 NYU Langone Health inpatient facilities, routine D-dimer surveillance for individuals with suspected or confirmed diagnoses of COVID-19 was included in COVID-19-specific admission order sets in the electronic heath record at the time of hospital admission starting March 25. At all NYU Langone Health sites, D-dimer assay was measured using the Hemosil D-dimer HS 500 on an automated coagulation analyzer (ACL TOP, Instrumentation Laboratory). The initial D-dimer and all D-dimers measured during hospital admission were recorded for all eligible patients. The upper limit of normal for the D-dimer assay is 230 ng/mL. Subjects were categorized into normal (D-dimer <230 ng/mL) and elevated (D-dimer ≥230 ng/mL) categories. We conducted sensitivity analyses using different D-Dimer categories: <230 ng/mL (normal), 230 to 500 ng/mL, 500 to 2000 ng/mL, and >2000 ng/mL.
Mass General Brigham COVID-19 Surveillance Study
Patients who presented to Mass General Brigham institutions with symptoms of fever, cough, sore throat, fatigue, muscle aches, or new anosmia; who were exposed to someone who tested positive for COVID-19; or who were referred by a health care provider were tested per specified testing criteria/guidelines set forth by the institution. Patients were diagnosed as infected with COVID-19 if SARS-CoV-2 RNA was detected in upper or lower respiratory specimens by nucleic acid testing (NAT) assays designated for emergency use authorization (EUA) by the Food and Drug Administration (FDA) and in accordance with the Centers for Disease Control and Prevention (CDC) guidelines [20 , 21 ]. Each assay targets at least 1 SARS-CoV-2 gene region; positive results are reported for each assay, as defined by the manufacturer or reference laboratory.
Comprehensive Electronic Health Record Analysis
Comprehensive Data Extraction from EHR
Multimodal Perioperative Data Aggregation
Tracking MRSA Resistance in EHR Data
Cardiovascular Disease and Noncardiac Surgery
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!